Examkin

Question

Difficulty: HardGastrointestinal and Abdominal Surgery

Match each pancreatic cystic lesion with its classic diagnostic finding, histologic characteristic, or indicated management strategy.

  • Serous cystadenomaBenign, microcystic (sponge-like) lesion often demonstrating a central stellate scar with calcification on imaging; safely managed with observation if asymptomatic.
  • Mucinous cystic neoplasmMacrocystic lesion lined by columnar epithelium with underlying ovarian-type stroma; typically found in the pancreatic body/tail and requires surgical resection.
  • Main-duct intraductal papillary mucinous neoplasm (IPMN)Characterized by diffuse dilation of the main pancreatic duct and extrusion of mucin from the ampulla of Vater; carries a high risk of malignant transformation.
  • Pancreatic pseudocystCollection of amylase-rich fluid surrounded by a wall of fibrous or granulation tissue lacking a true epithelial lining; generally managed by observation or drainage if symptomatic.

Answer

Serous cystadenoma matches with the benign lesion featuring a central stellate scar. Mucinous cystic neoplasm matches with the premalignant lesion containing ovarian-type stroma. Main-duct IPMN matches with ductal dilation and mucin extrusion. Pancreatic pseudocyst matches with the fluid collection lacking a true epithelial lining.
Appropriate matching relies on distinguishing the malignant potential and histopathology of each pancreatic cyst. Serous cystadenomas are benign with a central scar. MCNs have ovarian stroma and require resection. Main-duct IPMNs involve the main duct and have high malignant potential. Pseudocysts are inflammatory, non-epithelial structures.

Step-by-Step Solution

1
Analyze the histologic and radiographic features of Serous Cystadenoma.
Identify it as a benign, microcystic lesion with a central stellate scar.
Recognizing its benign nature prevents unnecessary surgical intervention for asymptomatic patients.
2
Examine the distinguishing feature of Mucinous Cystic Neoplasm.
Correlate it with ovarian-type stroma and macrocystic appearance.
This unique stroma is pathognomonic, and identifying it confirms the need for surgical resection due to malignant potential.
3
Identify the primary presentation of Main-duct IPMN.
Match it with diffuse dilation of the main pancreatic duct and mucin extrusion.
Main-duct involvement carries a very high risk of malignancy (up to 70%), making prompt identification and resection critical.
4
Determine the pathophysiologic origin of a Pancreatic pseudocyst.
Recognize it as an inflammatory fluid collection walled off by granulation tissue, lacking true epithelium.
Differentiating an inflammatory pseudocyst from a neoplastic cyst dictates a vastly different management pathway (drainage vs. resection).

Key Concept

Differentiation and surgical management of pancreatic cystic lesions based on histopathology and malignant potential.
Rate this question

Topics

Gastrointestinal and Abdominal Surgery

More questions from this topic